Ausgabe 1/2010
Inhalt (37 Artikel)
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?
Gary M. Tse, Puay-Hoon Tan
Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer
Rob Riemsma, C. A. Forbes, A. Kessels, K. Lykopoulos, M. M. Amonkar, D. W. Rea, J. Kleijnen
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study
Felice A. Tager, Paula S. McKinley, Freya R. Schnabel, Mahmoud El-Tamer, Ying Keun K. Cheung, Yixin Fang, Claire R. Golden, Margery E. Frosch, Ulya Habif, Margaret M. Mulligan, Ivy S. Chen, Dawn L. Hershman
The fog hasn’t lifted on “chemobrain” yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition
Janette Vardy, Haryana Dhillon
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
Johanna K. Morales, Maciej Kmieciak, Keith L. Knutson, Harry D. Bear, Masoud H. Manjili
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
Hugo Arias-Pulido, Melanie Royce, Yun Gong, Nancy Joste, Lesley Lomo, Sang-Joon Lee, Nabila Chaher, Claire Verschraegen, Juanita Lara, Eric R. Prossnitz, Massimo Cristofanilli
Gli1 promotes cell survival and is predictive of a poor outcome in ERα-negative breast cancer
Lusheng Xu, Yeon-Jin Kwon, Natalya Frolova, Adam D. Steg, Kun Yuan, Martin R. Johnson, William E. Grizzle, Renee A. Desmond, Andra R. Frost
A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient
Junma Zhou, Bruce Trock, Theodore N. Tsangaris, Neil B. Friedman, Deanna Shapiro, Michelle Brotzman, Yee Chan-Li, Daniel W. Chan, Jinong Li
Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
Atanas Ignatov, Tanja Ignatov, Albert Roessner, Serban Dan Costa, Thomas Kalinski
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
Erika Resetkova, Jorge S. Reis-Filho, Rohit K. Jain, Rutika Mehta, Mangesh A. Thorat, Harikrishna Nakshatri, Sunil Badve
Is ALDH1 a good method for definition of breast cancer stem cells?
Veronique Neumeister, David Rimm
Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer
Brenda Cohen, Mamiko Shimizu, Julia Izrailit, Nancy F. L. Ng, Yuri Buchman, James G. Pan, Judy Dering, Michael Reedijk
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue
In Hae Park, Youngmee Kwon, Jae Y. Ro, Keun Seok Lee, Jungsil Ro
Concordance of HER2 in primary tumor and leptomeningeal metastases: now what?
Nancy U. Lin
Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population
A-Yong Cao, Ke-Da Yu, Wen-Jin Yin, Wei Jin, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells
Tisheeka R. Graham, Rami Yacoub, LaTonia Taliaferro-Smith, Adeboye O. Osunkoya, Valerie A. Odero-Marah, Tongrui Liu, K. Sean Kimbro, Dipali Sharma, Ruth M. O’Regan
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Miguel Martín, Álvaro Rodríguez-Lescure, Amparo Ruiz, Emilio Alba, Lourdes Calvo, Manuel Ruiz-Borrego, Ana Santaballa, César A. Rodríguez, Carmen Crespo, Mar Abad, Severina Domínguez, Jesús Florián, Cristina Llorca, Miguel Méndez, María Godes, Ricardo Cubedo, Adolfo Murias, Norberto Batista, María José García, Rosalía Caballero, Enrique de Álava
CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D
Katrín Á. Gunnarsdóttir, Maj-Britt Jensen, David Zahrieh, Richard D. Gelber, Ann Knoop, Marco Bonetti, Henning Mouridsen, Bent Ejlertsen
Re-searching anthracycline therapy
Catherine Oakman, Erica Moretti, Angelo Di Leo
Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival
Jung Ah Lee, Kwan-Il Kim, Jeoung Won Bae, Young-Hoon Jung, Hyonggin An, Eun Sook Lee
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
A. A. Rodriguez, A. Makris, M. F. Wu, M. Rimawi, A. Froehlich, B. Dave, S. G. Hilsenbeck, G. C. Chamness, M. T. Lewis, L. E. Dobrolecki, D. Jain, S. Sahoo, C. K. Osborne, J. C. Chang
Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer
Meng Qi, Jin Feng Li, Yun Tao Xie, Ai Ping Lu, Ben Yao Lin, Tao Ouyang
Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis
Zheng Jiang, Chunxiang Li, Ye Xu, Sanjun Cai, Xishan Wang
Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects
Meiping Lu, Feng Wang, Jinrong Qiu
XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects
Ke-Da Yu, Ao-Xiang Chen, Li-Xin Qiu, Lei Fan, Chen Yang, Zhi-Ming Shao
The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects
Lei Yao, Li-Xin Qiu, Lu Yu, Zhen Yang, Xia-Jia Yu, Yang Zhong, Xi-Chun Hu, Long Yu
Global breast cancer seasonality
Eun-Young Oh, Christine Ansell, Hamayun Nawaz, Chul-Ho Yang, Patricia A. Wood, William J. M. Hrushesky
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer
Gretchen L. Gierach, Jennifer T. Loud, Catherine K. Chow, Sheila A. Prindiville, Jennifer Eng-Wong, Peter W. Soballe, Claudia Giambartolomei, Phuong L. Mai, Claudia E. Galbo, Kathryn Nichols, Kathleen A. Calzone, Celine Vachon, Mitchell H. Gail, Mark H. Greene
Population-based survival-cure analysis of ER-negative breast cancer
Lan Huang, Karen A. Johnson, Angela B. Mariotto, James J. Dignam, Eric J. Feuer
COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies
Haixia Ding, Yuanyuan Fu, Weixian Chen, Zhanwei Wang
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells
Mahvash Zakikhani, Marie-José Blouin, Esther Piura, Michael N. Pollak
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature
Rebecca Peare, R. T. Staff, S. D. Heys
Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2
Josefa Salgado, Cristina Gutiérrez, Carmen Gil, Maitane Robles, Jesús García-Foncillas
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode
Robert E. Neal II, Ravi Singh, Heather C. Hatcher, Nancy D. Kock, Suzy V. Torti, Rafael V. Davalos
Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer
Robert J. Paridaens, Shari Gelber, Bernard F. Cole, Richard D. Gelber, Beat Thürlimann, Karen N. Price, Stig B. Holmberg, Diana Crivellari, Alan S. Coates, Aron Goldhirsch
Is there a role for ovarian function suppression in operable breast cancer?
Joseph A. Sparano